About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
New treatments for irritable bowel syndrome, erectile dysfunction, and postherpetic neuralgia
Marvin M. Goldenberg, PhD
The author discusses the effects of various drugs on the cardiac QTc interval.
Alan Hopefl, PharmD
The increasing use of complementary and alternative remedies presents a challenge to pharmacists as they strive to ensure rational drug therapy.
Kenneth R. Cohen, PhD, RPh, Peter Cerone, MS, RPh, and Robert Ruggiero, PharmD
Short-Term Cost-Effectiveness of Bisphosphonate Therapies for Postmenopausal Osteoporotic Women at High Risk of Fracture
The authors evaluated the budget impact of risedronate and alendronate
in the treatment of patients with postmenopausal osteoporosis.
D. T. Grima, MSc, R. T. Burge, PhD, D. L. Becker, MSc, and A. N. A. Tosteson, ScD
The authors review vaccines included on the recommended childhood
immuzation schedule that are currently in short supply and propose
suggestions for tracking patients affected by vaccine shortages.
S. Jay Weaver, PharmD, and Paul L. Doering, MS Pharm
In an effort to inform and safeguard the growing number of consumers
who use dietary supplements, the U.S. Pharmacopeia (USP) has developed the Dietary Supplement Verification Program.
Editor-in-Chief David Nash discusses “Prophylactic Ethics” in the age of genomics.
David B. Nash, MD, MBA
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Matthew Grissinger, RPh, discusses savings that can result from implementing CPOE systems.
DHHS sets marketing hurdle for PBMs.